In April 2016, the European Parliament adopted the General Data Protection Regulation (GDPR) to modernize its data protection legislation. As of May 25, 2018, the Data Protection Directive was thus repealed and replaced by the GDPR, while all member states legislation became subject to review to be aligned with the GDPR, leading to major modifications of the rules that prevailed prior to the GDPR coming into force.
For research trials, enacting the GDPR had a number of implications, both for sponsors, contract research organizations (CROs) and trial sites located in the European Union (EU), and for some foreign CROs and sponsors, which now need to comply with various obligations failing which they may be exposed to heavy fines and other legal recourses.
Click here to read about the various obligations that must be complied with.
While capital markets rely on companies to provide timely and accurate information, and investors, shareholders and others rely on companies to provide financial reports that have been through a rigorous audit process, government and regulators in the UK recognise that the COVID-19 pandemic is creating huge challenges for both corporate reporting and audit processes.
On April 23, 2020, the UK Government announced additional temporary restrictions on commercial landlords pursuing outstanding rent (see our Briefing). It has now published full details.
The energy transition is firmly underway. While global demand for energy continues to rise, increasing pressure from governments, investors, and consumers to support the decarbonisation of the industry has spearheaded radical change.
Subscribe and stay up to date with the latest legal news, information and events...
